Exploring the oncogenic mechanism of plasmacytoma variant translocation 1 (PVT1) gene in solid cancers; emphasis on...

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• PVT1 is a versatile non-coding RNA (ncRNA) involved in critical cellular processes like survival, differentiation, proliferation, and chromatin regulation.
• PVT1 functions as a scaffold, decoy, guide, or enhancer RNA, influencing gene expression throughout its lifecycle via epigenetic and post-transcriptional mechanisms.

Purpose of the Study:

• To comprehensively analyze the multifaceted roles and mechanisms of PVT1 in cancer development and progression.
• To elucidate the intricate relationship between PVT1, microRNAs (miRNAs), and cancer pathogenesis.
• To identify potential therapeutic strategies targeting PVT1 and its associated signaling pathways.

Main Methods:

• Extensive literature review and analysis of PVT1 functions in various biological contexts.
• Examination of PVT1's role in gene regulation, including chromatin remodeling and epigenetic modifications.
• Analysis of PVT1 expression patterns in different human cancers and their correlation with clinical outcomes.

Main Results:

• PVT1 overexpression significantly increases cell proliferation (up to 30%) and decreases apoptosis.
• PVT1 fusion transcripts are prevalent in various solid tumors and hematological malignancies.
• High PVT1 expression correlates with advanced cancer stage, metastasis, and reduced patient survival.

Conclusions:

• Upregulated PVT1 is a critical driver of carcinogenesis and tumor metastasis.
• PVT1's complex regulatory functions underscore its importance in cancer biology.
• PVT1 expression serves as a promising prognostic biomarker for various human cancers, offering potential therapeutic targets.